Participations à des congrès et colloques internationaux (137)
30.
Wauthoz, N., Hennia, I., Deleers, M., Diez, F., & Amighi, K. (2015). Inhaler Device Selection: comparison of capsule-based DPIs, pMDIs and Multi-dose DPIs. Paper session presented at American Association of Pharmaceutical Scientists : Annual Meeting & Exposition (2015: 25-29/10/2015: Orlando, USA).31.
Schoubben, A., Wauthoz, N., Ianni, F., Blasi, P., Amighi, K., & Ricci, M. (2015). Aerodynamic properties and pharmacokinetics of capreomycin oleate supergenerics. Paper session presented at Inhaled Therapies for tuberculosis and other infectious diseases (3rd: 14-16/10/2015: Parma, Italy).32.
Wauthoz, N., Duret, C., Merlos, R., Sebti, T., Vanderbist, F., & Amighi, K. (2015). Innovative dry itraconazole-based solid dispersion for inhalation to combat pulmonary aspergillosis : from the laboratory bench to the industrial scale. Poster présenté à la conférence Inhaled Therapies for Tuberculosis and other infectious diseases (3rd: 14-16/10/2015: Parma, Italy).33.
Ianni, F., Schoubben, A., Lisanti, A., Sardella, R., Wauthoz, N., Amighi, K., & Natalini, B. (2015). QUANTITATIVE ASSAY OF CAPREOMYCIN OLEATE LEVELS IN MICE LUNG AND PLASMA WITH A FULLY VALIDATED RP-HPLC METHOD. Poster présenté à la conférence RDPA 2015 Recent Development in Pharmaceutical Analysis (28/06/2015-1/07/2015: Perugia, Italy).34.
Merlos, R., Wauthoz, N., Belhassan, L., Sebti, T., Traina, K., Vanderbist, F., & Amighi, K. (2015). Scaling-up of an Itraconazole-based Dry Powder for Inhalation from a Lab-sized Buchi Mini Spray Dryer B-290 to a Pilot Mobile Minor Spray Dryer. Paper session presented at Forum des sciences pharmaceutiques de la SBSP (18: 28-29/05/2015: Blankenberge).36.
Wauthoz, N., Hennia, I., Deleers, M., Diez, F., & Amighi, K. (2015). Inhaler Device Selection: comparison of capsule-based DPIs, pMDIs and Multi-dose DPIs. Paper session presented at RDD Europe 2015 (5-8 May 2015: Antibes, France).37.
Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., Mathivet, T., & De Vleeschouwer, S. (2015). Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo- and immunotherapy for glioblastoma. Poster présenté à la conférence European Conference on Pharmaceutics (1st: 13 and 14/04/2015: Reims, France).38.
Rosiere, R., Van Woensel, M., Langer, I., Mathieu, V., Amighi, K., & Wauthoz, N. (2015). Nanomicelle-based dry powders for inhalation for targeted delivery to lung cancer cells: in vitro evaluation and in vivo local pulmonary tolerance on healthy mice. Poster présenté à la conférence European Conference on Pharmaceutics (1st: 13 and 14/04/2015: Reims, France).39.
Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., & De Vriese, C. (2015). Design of an implementation study related to an interdisciplinary ART adherence program for HIV patients in community pharmacies. International Journal of Clinical Pharmacy,(37), 419.40.
Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2015). Design of an implementation study related to an interdisciplinary ART adherence program for HIV patients in community pharmacies. Poster présenté à la conférence Pharmaceutical Care Network Europe Working Conference (4-6 feb 2015: Mechelen, Belgium).41.
Merlos, R., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2014). Industrial perspectives for Dry Powder for Inhalation composed by Itraconazole to prevent or combat pulmonary aspergillosis. Poster présenté à la conférence Journée doctorale Pôle Santé (14ème: 18/12/2014: Campus Erasme, ULB).